# Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy

Study · id `cardio:ct-nct03343366` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03343366](<https://clinicaltrials.gov/study/NCT03343366>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03343366

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT03343366. Randomized; single masking; primary purpose prevention. Start 2018-01-01 (actual); primary completion 2020-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT03343366, source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)
- Started: 2018-01-01 (actual) (ClinicalTrials.gov record NCT03343366, source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)
- Primary completion: 2020-06-30 (actual) (ClinicalTrials.gov record NCT03343366, source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)
- Completion: 2020-07-30 (actual) (ClinicalTrials.gov record NCT03343366, source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)
- Countries: Pakistan (ClinicalTrials.gov record NCT03343366, source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03343366-2020-08-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Glycemic Control in T2DM Through Non-Surgical Periodontal Therapy
- Condition: Chronic Periodontitis
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): Metronidazole
- Intervention (Procedure): Scaling Root Planing
- Intervention (Behavioral): Oral Hygiene Instructions
- Lead sponsor: Dow University of Health Sciences
- Lead sponsor class: OTHER
- Collaborator: Higher Education Commission (Pakistan)
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Dow University of Health Sciences (`cardio:org-dow-university-of-health-sciences`)

## Provenance

Content hash: c5bdfc20df9dd95d4e23b56ec24049d8fa57d0111af575affb00c0b433751c4b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
